Nicholas Stergis - Miami FL, US George B. McDonald - Bellevue WA, US
Assignee:
Soligenix, Inc. - Princeton NJ
International Classification:
A61K 31/573 A61K 31/56 A61K 31/59
US Classification:
514179, 514167, 514169
Abstract:
A method of administration of an oral pharmaceutical product to patients suffering from inflammatory disorders of the gastrointestinal tract comprises orally administering to the patient at least two different dosage forms of a therapeutically effective amount of a topically active corticosteroid, such as beclomethasone dipropionate (BDP).